Myocardial Ischemia
|
0.310 |
Biomarker
|
disease |
CTD_human |
Cardioplegia prevents ischemia-induced transcriptional alterations of cytoprotective genes in rat hearts: a DNA microarray study.
|
16214533 |
2005 |
Carcinoma
|
0.310 |
Biomarker
|
group |
CTD_human |
By quantitative real-time PCR, the mRNA expression of Rasa, Pi3kr1, Ccnh, and Il6st in carcinomas was, respectively, 22-, 20-, three- and threefold higher in carcinomas than in control mammary gland tissues (P<0.05, Student's t-test).
|
12606953 |
2003 |
ovarian neoplasm
|
0.310 |
Biomarker
|
disease |
CTD_human |
Coexpression of IL-11Ralpha and gp130 was commonly observed in both benign ovarian tumors and in the epithelial layer of normal ovaries.
|
11161848 |
2001 |
Malignant neoplasm of ovary
|
0.310 |
Biomarker
|
disease |
CTD_human |
In 45 primary ovarian carcinoma samples where both components of the IL-11 receptor (IL-11Ralpha and gp130) were examined, coexpression was observed in 42 (93.3%).
|
11161848 |
2001 |
Eosinophilia
|
0.300 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Loss of the interleukin-6 receptor causes immunodeficiency, atopy, and abnormal inflammatory responses.
|
31235509 |
2019 |
Increased IgE level
|
0.300 |
Biomarker
|
phenotype |
GENOMICS_ENGLAND |
Loss of the interleukin-6 receptor causes immunodeficiency, atopy, and abnormal inflammatory responses.
|
31235509 |
2019 |
Recurrent infections
|
0.300 |
Biomarker
|
phenotype |
GENOMICS_ENGLAND |
Loss of the interleukin-6 receptor causes immunodeficiency, atopy, and abnormal inflammatory responses.
|
31235509 |
2019 |
Prostatic Neoplasms
|
0.300 |
Biomarker
|
group |
CTD_human |
The long tail of oncogenic drivers in prostate cancer.
|
29610475 |
2018 |
Prostatic Neoplasms
|
0.300 |
Biomarker
|
group |
CTD_human |
Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets.
|
29662167 |
2018 |
Malignant neoplasm of prostate
|
0.300 |
Biomarker
|
disease |
CTD_human |
The long tail of oncogenic drivers in prostate cancer.
|
29610475 |
2018 |
Malignant neoplasm of prostate
|
0.300 |
Biomarker
|
disease |
CTD_human |
Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets.
|
29662167 |
2018 |
Hypersensitivity
|
0.300 |
Biomarker
|
group |
CTD_human |
Expansion of CD4(+) CD25(+) and CD25(-) T-Bet, GATA-3, Foxp3 and RORγt cells in allergic inflammation, local lung distribution and chemokine gene expression.
|
21625544 |
2011 |
Lobar Pneumonia
|
0.300 |
Biomarker
|
disease |
CTD_human |
Expansion of CD4(+) CD25(+) and CD25(-) T-Bet, GATA-3, Foxp3 and RORγt cells in allergic inflammation, local lung distribution and chemokine gene expression.
|
21625544 |
2011 |
Reperfusion Injury
|
0.300 |
Biomarker
|
disease |
CTD_human |
Neuroprotection by interleukin-6 is mediated by signal transducer and activator of transcription 3 and antioxidative signaling in ischemic stroke.
|
21940958 |
2011 |
Middle Cerebral Artery Syndrome
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Neuroprotection by interleukin-6 is mediated by signal transducer and activator of transcription 3 and antioxidative signaling in ischemic stroke.
|
21940958 |
2011 |
Middle Cerebral Artery Thrombosis
|
0.300 |
Biomarker
|
disease |
CTD_human |
Neuroprotection by interleukin-6 is mediated by signal transducer and activator of transcription 3 and antioxidative signaling in ischemic stroke.
|
21940958 |
2011 |
Middle Cerebral Artery Occlusion
|
0.300 |
Biomarker
|
disease |
CTD_human |
Neuroprotection by interleukin-6 is mediated by signal transducer and activator of transcription 3 and antioxidative signaling in ischemic stroke.
|
21940958 |
2011 |
Infarction, Middle Cerebral Artery
|
0.300 |
Biomarker
|
disease |
CTD_human |
Neuroprotection by interleukin-6 is mediated by signal transducer and activator of transcription 3 and antioxidative signaling in ischemic stroke.
|
21940958 |
2011 |
Middle Cerebral Artery Embolus
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Neuroprotection by interleukin-6 is mediated by signal transducer and activator of transcription 3 and antioxidative signaling in ischemic stroke.
|
21940958 |
2011 |
Left Middle Cerebral Artery Infarction
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Neuroprotection by interleukin-6 is mediated by signal transducer and activator of transcription 3 and antioxidative signaling in ischemic stroke.
|
21940958 |
2011 |
Embolic Infarction, Middle Cerebral Artery
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Neuroprotection by interleukin-6 is mediated by signal transducer and activator of transcription 3 and antioxidative signaling in ischemic stroke.
|
21940958 |
2011 |
Thrombotic Infarction, Middle Cerebral Artery
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Neuroprotection by interleukin-6 is mediated by signal transducer and activator of transcription 3 and antioxidative signaling in ischemic stroke.
|
21940958 |
2011 |
Right Middle Cerebral Artery Infarction
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Neuroprotection by interleukin-6 is mediated by signal transducer and activator of transcription 3 and antioxidative signaling in ischemic stroke.
|
21940958 |
2011 |
Experimental Lung Inflammation
|
0.300 |
Biomarker
|
disease |
CTD_human |
Expansion of CD4(+) CD25(+) and CD25(-) T-Bet, GATA-3, Foxp3 and RORγt cells in allergic inflammation, local lung distribution and chemokine gene expression.
|
21625544 |
2011 |
Allergic Reaction
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Expansion of CD4(+) CD25(+) and CD25(-) T-Bet, GATA-3, Foxp3 and RORγt cells in allergic inflammation, local lung distribution and chemokine gene expression.
|
21625544 |
2011 |